SCHEMBL8319601

SCHEMBL8319601

Cc1cccc(Nc2nc(Cl)nc3c(Cl)ncnc23)c1

nearest known ligand 0.60

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
EGFR P00533 12/20 0.60
NFKB1 P19838 1/20 0.54
HTT P42858 2/20 0.47
HIF1A Q16665 1/20 0.47
POLB P06746 1/20 0.46
MAPK1 P28482 2/20 0.45
ERBB2 P04626 2/20 0.45
ABL1 P00519 2/20 0.45
ABL2 P42684 1/20 0.45
TSHR P16473 1/20 0.45
RAB9A P51151 1/20 0.45
GFER P55789 1/20 0.45
SMN1; SMN2 Q16637 1/20 0.45
HSD17B10 Q99714 1/20 0.45
AURKA O14965 1/20 0.44
SRC P12931 1/20 0.44
PRKCA P17252 1/20 0.44
KDM4E B2RXH2 1/20 0.43
LMNA P02545 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8315093 0.86 EGFR (0.50) EGFRHTTERBB2ABL1ABL2
SCHEMBL8318036 0.84 EGFR (0.60) EGFR
SCHEMBL8316202 0.83 EGFR (0.55) EGFRNFKB1MAPK1ERBB2ABL1
SCHEMBL8316388 0.81 TRPV1 (0.52) EGFRHTTPOLBTSHRSMN1; SMN2
SCHEMBL12755665 0.77 NFKB1 (0.62) EGFRNFKB1HTTHIF1APOLB
SCHEMBL27248335 0.77 NFKB1 (0.55) EGFRNFKB1HTTHIF1APOLB
SCHEMBL10501815 0.76 KHK (0.46) HTTTSHRRAB9ASMN1; SMN2HSD17B10
SCHEMBL9945497 0.73 EGFR (0.64) EGFRNFKB1HTTHIF1APOLB
SCHEMBL9945499 0.73 EGFR (0.64) EGFRNFKB1HTTHIF1APOLB
SCHEMBL30394764 0.73 EGFR (0.64) EGFRNFKB1HTTHIF1APOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0779888-B1 PYRIMIDO [5,4-D]PYRIMIDINES, DRUGS CONTAINING THESE COMPOUNDS, THEIR USE, AND PROCESS FOR PREPARING THEM BOEHRINGER INGELHEIM PHARMA (DE) 1999-04-28 EP disclosed
US-5707989-A ANTITUMOR AGENTS, INHIBITING SIGNAL TRANSDUCTION MEDIATED BY TYROSINE KINASES DR. KARL THOMAE GMBH (DE) 1998-01-13 US disclosed